185 related articles for article (PubMed ID: 36825535)
1. Cell-free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients.
Trier Maansson C; Meldgaard P; Stougaard M; Nielsen AL; Sorensen BS
Mol Oncol; 2023 May; 17(5):722-736. PubMed ID: 36825535
[TBL] [Abstract][Full Text] [Related]
2. EGFR transcription in non-small-cell lung cancer tumours can be revealed in ctDNA by cell-free chromatin immunoprecipitation (cfChIP).
Månsson CT; Vad-Nielsen J; Meldgaard P; Nielsen AL; Sorensen BS
Mol Oncol; 2021 Nov; 15(11):2868-2876. PubMed ID: 34453867
[TBL] [Abstract][Full Text] [Related]
3. Cell-free Chromatin Immunoprecipitation (cfChIP) from blood plasma can determine gene-expression in tumors from non-small-cell lung cancer patients.
Vad-Nielsen J; Meldgaard P; Sorensen BS; Nielsen AL
Lung Cancer; 2020 Sep; 147():244-251. PubMed ID: 32759018
[TBL] [Abstract][Full Text] [Related]
4. Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies.
Maansson CT; Thomsen LS; Meldgaard P; Nielsen AL; Sorensen BS
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279243
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
[TBL] [Abstract][Full Text] [Related]
6. Differences in the genomic profiles of cell-free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC.
Wu Z; Yang Z; Li CS; Zhao W; Liang ZX; Dai Y; Zhu Q; Miao KL; Cui DH; Chen LA
Cancer Med; 2019 Mar; 8(3):910-919. PubMed ID: 30767431
[TBL] [Abstract][Full Text] [Related]
7. Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.
Du M; Thompson J; Fisher H; Zhang P; Huang CC; Wang L
Lung Cancer; 2018 Jun; 120():113-121. PubMed ID: 29748005
[TBL] [Abstract][Full Text] [Related]
8. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
Heeke S; Gay CM; Estecio MR; Tran H; Morris BB; Zhang B; Tang X; Raso MG; Rocha P; Lai S; Arriola E; Hofman P; Hofman V; Kopparapu P; Lovly CM; Concannon K; De Sousa LG; Lewis WE; Kondo K; Hu X; Tanimoto A; Vokes NI; Nilsson MB; Stewart A; Jansen M; Horváth I; Gaga M; Panagoulias V; Raviv Y; Frumkin D; Wasserstrom A; Shuali A; Schnabel CA; Xi Y; Diao L; Wang Q; Zhang J; Van Loo P; Wang J; Wistuba II; Byers LA; Heymach JV
Cancer Cell; 2024 Feb; 42(2):225-237.e5. PubMed ID: 38278149
[TBL] [Abstract][Full Text] [Related]
9. Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung Cancer.
Gray J; Thompson JC; Carpenter EL; Elkhouly E; Aggarwal C
Oncologist; 2021 Oct; 26(10):e1812-e1821. PubMed ID: 34216176
[TBL] [Abstract][Full Text] [Related]
10. Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma.
Raman L; Van der Linden M; Van der Eecken K; Vermaelen K; Demedts I; Surmont V; Himpe U; Dedeurwaerdere F; Ferdinande L; Lievens Y; Claes K; Menten B; Van Dorpe J
Genome Med; 2020 Apr; 12(1):35. PubMed ID: 32317009
[TBL] [Abstract][Full Text] [Related]
11. Cell-free chromatin immunoprecipitation to detect molecular pathways in heart transplantation.
Jang MK; Markowitz TE; Andargie TE; Apalara Z; Kuhn S; Agbor-Enoh S
Life Sci Alliance; 2023 Dec; 6(12):. PubMed ID: 37730434
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Bustamante Alvarez JG; Janse S; Owen DH; Kiourtsis S; Bertino EM; He K; Carbone DP; Otterson GA
Clin Lung Cancer; 2021 Jul; 22(4):e519-e527. PubMed ID: 33414052
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse.
Almodovar K; Iams WT; Meador CB; Zhao Z; York S; Horn L; Yan Y; Hernandez J; Chen H; Shyr Y; Lim LP; Raymond CK; Lovly CM
J Thorac Oncol; 2018 Jan; 13(1):112-123. PubMed ID: 28951314
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
[TBL] [Abstract][Full Text] [Related]
16. ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin.
Sadeh R; Sharkia I; Fialkoff G; Rahat A; Gutin J; Chappleboim A; Nitzan M; Fox-Fisher I; Neiman D; Meler G; Kamari Z; Yaish D; Peretz T; Hubert A; Cohen JE; Salah A; Temper M; Grinshpun A; Maoz M; Abu-Gazala S; Ben Ya'acov A; Shteyer E; Safadi R; Kaplan T; Shemer R; Planer D; Galun E; Glaser B; Zick A; Dor Y; Friedman N
Nat Biotechnol; 2021 May; 39(5):586-598. PubMed ID: 33432199
[TBL] [Abstract][Full Text] [Related]
17. Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions.
Hiatt JB; Doebley AL; Arnold HU; Adil M; Sandborg H; Persse TW; Ko M; Wu F; Quintanal Villalonga A; Santana-Davila R; Eaton K; Dive C; Rudin CM; Thomas A; Houghton AM; Ha G; MacPherson D
Sci Adv; 2024 Apr; 10(15):eadk2082. PubMed ID: 38598634
[TBL] [Abstract][Full Text] [Related]
18. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer.
He T; Wildey G; McColl K; Savadelis A; Spainhower K; McColl C; Kresak A; Tan AC; Yang M; Abbas A; Dowlati A
Mol Oncol; 2021 Jan; 15(1):195-209. PubMed ID: 33084222
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital.
Ghosh M; Mukhopadhyay M; Das C; Chatterjee S; Naskar BG
J Cancer Res Ther; 2021; 17(6):1389-1396. PubMed ID: 34916369
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.
Yanagita M; Redig AJ; Paweletz CP; Dahlberg SE; O'Connell A; Feeney N; Taibi M; Boucher D; Oxnard GR; Johnson BE; Costa DB; Jackman DM; Jänne PA
Clin Cancer Res; 2016 Dec; 22(24):6010-6020. PubMed ID: 27281561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
